Commission Implementing Regulation (EU) 2021/1280 of 2 August 2021 as regards measures on good distribution practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)
Article 21Returns
In force · version of Aug 23, 2021
1.Returned active substances used as starting materials in veterinary medicinal products shall be identified as such and segregated physically or, if an equivalent electronic system is available, electronically, pending the outcome of an investigation into those returned active substances.
2.Active substances used as starting materials in veterinary medicinal products which have left the care of the persons referred to in Article 1(2) shall only be returned to saleable stock if all of the following conditions are met: (a) the active substance used as a starting material in veterinary medicinal products is in its original unopened containers with all original security seals present and is in good condition; (b) it is demonstrated by written information provided by the customer that the active substance used as a starting material in veterinary medicinal products has been stored and handled under proper conditions; (c) the remaining shelf life is acceptable; (d) the active substance used as a starting material in veterinary medicinal products has been examined and assessed by a person trained and authorised to do so; (e) no loss of information or traceability has occurred.
3.The assessment under paragraph (2) shall take into account the nature of the active substance used as a starting material in veterinary medicinal products, any special storage conditions it requires and the time elapsed since it was supplied. As necessary and if there is any doubt about the quality of the returned active substance used as a starting material in veterinary medicinal products, advice shall be sought from the original active substance manufacturer.
4.Records of returned active substances used as starting materials in veterinary medicinal products shall be maintained. For each return, documentation shall include the following: (a) name or company name and permanent address or registered place of business of the consignee returning the active substance used as starting materials in veterinary medicinal products; (b) name or designation of the active substance used as a starting material in veterinary medicinal products; (c) batch number of the active substance used as a starting material in veterinary medicinal products; (d) quantity of active substance used as a starting material in veterinary medicinal products returned; (e) reason for return; (f) use or disposal of the returned active substance used as a starting material in veterinary medicinal products and records of the assessment performed.
5.Only appropriately trained and authorised personnel shall release active substances used as starting materials in veterinary medicinal products for return to saleable stock.
6.Active substances used as starting materials in veterinary medicinal products returned to saleable stock shall be placed so that the stock rotation system operates effectively.